Insufficient scRNA-seq data for expression of FUT5 at single-cell level.
Insufficient scRNA-seq data for expression of FUT5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 96% | 11.81 | 216 / 226 | 1% | 0.01 | 3 / 406 |
brain | 68% | 4.50 | 1800 / 2642 | 0% | 0 | 0 / 705 |
skin | 66% | 9.40 | 1201 / 1809 | 0% | 0 | 0 / 472 |
esophagus | 65% | 7.60 | 933 / 1445 | 0% | 0 | 0 / 183 |
intestine | 64% | 5.77 | 614 / 966 | 0% | 0.00 | 1 / 527 |
prostate | 58% | 2.76 | 141 / 245 | 0% | 0 | 0 / 502 |
kidney | 54% | 3.21 | 48 / 89 | 0% | 0 | 0 / 901 |
breast | 48% | 2.92 | 222 / 459 | 0% | 0.00 | 1 / 1118 |
bladder | 48% | 2.05 | 10 / 21 | 0% | 0 | 0 / 504 |
lung | 44% | 2.37 | 257 / 578 | 0% | 0.00 | 1 / 1155 |
adipose | 42% | 3.32 | 507 / 1204 | 0% | 0 | 0 / 0 |
stomach | 39% | 2.26 | 140 / 359 | 0% | 0 | 0 / 286 |
spleen | 39% | 1.44 | 93 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 38% | 2.06 | 355 / 929 | 0% | 0 | 0 / 0 |
uterus | 35% | 1.35 | 59 / 170 | 1% | 0.04 | 5 / 459 |
pancreas | 35% | 1.12 | 116 / 328 | 0% | 0 | 0 / 178 |
blood vessel | 33% | 1.52 | 437 / 1335 | 0% | 0 | 0 / 0 |
ovary | 28% | 1.54 | 50 / 180 | 0% | 0.01 | 1 / 430 |
heart | 27% | 0.92 | 229 / 861 | 0% | 0 | 0 / 0 |
thymus | 19% | 0.54 | 127 / 653 | 0% | 0 | 0 / 605 |
muscle | 16% | 0.82 | 132 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 12% | 0.37 | 32 / 258 | 0% | 0 | 0 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0006672 | Biological process | ceramide metabolic process |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0009312 | Biological process | oligosaccharide biosynthetic process |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0042355 | Biological process | L-fucose catabolic process |
GO_0009311 | Biological process | oligosaccharide metabolic process |
GO_0006486 | Biological process | protein glycosylation |
GO_0036065 | Biological process | fucosylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0017060 | Molecular function | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity |
GO_0046920 | Molecular function | alpha-(1->3)-fucosyltransferase activity |
GO_0008417 | Molecular function | fucosyltransferase activity |
GO_0017083 | Molecular function | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
Gene name | FUT5 |
Protein name | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 (EC 2.4.1.152) (3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT5) (EC 2.4.1.65) (Fucosyltransferase 5) (Fucosyltransferase V) (Fuc-TV) (FucT-V) (Galactoside 3-L-fucosyltransferase) |
Synonyms | |
Description | FUNCTION: Catalyzes preferentially the transfer of L-fucose, from a guanosine diphosphate-beta-L-fucose, to the N-acetyl-beta-D-glucosamine (GlcNAc) of an N-acetyllactosamine unit (type 2 chain) of an oligosaccharide, or a glycoprotein- and a glycolipid-linked N-acetyllactosamine unit via an alpha (1,3) linkage and participates in the surface expression of VIM-2, Lewis X/SSEA-1 and sialyl Lewis X antigens . Preferentially transfers fucose to the GlcNAc of an internal N-acetyllactosamine unit of a poly-N-acetyllactosamine chain acceptor substrate . Also catalyzes to a lesser extend the transfer of L-fucose to the GlcNAc of a type 1 (beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl) or H-type 1 (alpha-L-Fuc-(1->2)-beta-D-Gal-(1->3)-D-GlcNAc) chain oligosaccharide via an alpha (1,4) linkage . Preferentially catalyzes sialylated type 2 oligosaccharide acceptors over neutral type 2 or H type 2 (alpha-L-Fuc-(1->2)-beta-D-Gal-(1->4)-D-GlcNAc) oligosaccharide acceptors . Lactose-based structures are also acceptor substrates . . |
Accessions | ENST00000588525.1 Q11128 ENST00000252675.6 |